BCL2 and colonic neoplasm: In this study, the pro-apoptotic markers (p53, Bax, Bid and PARP) were upregulated and anti-apoptotic markers (Bcl2 and Nrf2) were downregulated after the treatment of sacubitrilat and SAHA in colon cancer (Fig. 11).